CRYO CELL INTERNATIONAL INCCCELEarnings & Financial Report
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.
CCEL Q4 2025 Key Financial Metrics
Revenue
$7.8M
Gross Profit
$6.1M
Operating Profit
$-4.0M
Net Profit
$-3.8M
Gross Margin
77.9%
Operating Margin
-50.6%
Net Margin
-48.7%
YoY Growth
-2.3%
EPS
$-0.46
Financial Flow
CRYO CELL INTERNATIONAL INC Q4 2025 Financial Summary
CRYO CELL INTERNATIONAL INC reported revenue of $7.8M (down 2.3% YoY) for Q4 2025, with a net profit of $-3.8M (down 105.1% YoY) (-48.7% margin). Cost of goods sold was $1.7M, operating expenses totaled $10.1M.
Key Financial Metrics
| Total Revenue | $7.8M |
|---|---|
| Net Profit | $-3.8M |
| Gross Margin | 77.9% |
| Operating Margin | -50.6% |
| Report Period | Q4 2025 |
CRYO CELL INTERNATIONAL INC Annual Revenue by Year
CRYO CELL INTERNATIONAL INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $31.6M). Click any linked year to see what changed vs the prior annual report.
CRYO CELL INTERNATIONAL INC Quarterly Revenue & Net Profit History
CRYO CELL INTERNATIONAL INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $7.8M | -2.3% | $-3.8M | -48.7% |
| Q3 2025 | $7.8M | -3.0% | $749.4K | 9.6% |
| Q2 2025 | $7.9M | -1.4% | $355.8K | 4.5% |
| Q1 2025 | $8.0M | +1.5% | $282.9K | 3.5% |
| Q4 2024 | $8.0M | +1.9% | $-1.9M | -23.2% |
| Q3 2024 | $8.1M | +2.5% | $1.1M | 13.0% |
| Q2 2024 | $8.0M | +3.5% | $655.8K | 8.2% |
| Q1 2024 | $7.9M | +0.4% | $556.2K | 7.1% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.9M | $8.0M | $8.1M | $8.0M | $8.0M | $7.9M | $7.8M | $7.8M |
| YoY Growth | 0.4% | 3.5% | 2.5% | 1.9% | 1.5% | -1.4% | -3.0% | -2.3% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $61.7M | $62.6M | $62.9M | $64.7M | $64.4M | $64.4M | $63.2M | $61.7M |
| Liabilities | $72.0M | $73.3M | $72.5M | $77.9M | $79.0M | $80.0M | $78.0M | $80.3M |
| Equity | $-10.3M | $-10.7M | $-9.6M | $-13.2M | $-14.7M | $-15.6M | $-14.8M | $-18.6M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-356865 | $1.8M | $2.4M | $2.2M | $954063 | $707014 | $2.5M | $1.3M |